263rd ENMC International Workshop: Focus on female carriers of dystrophinopathy: refining recommendations for prevention, diagnosis, surveillance, and treatment. Hoofddorp, The Netherlands, 13-15 May 2022

Publikation: Bidrag til tidsskriftKonferenceartikelForskningfagfællebedømt

  • Anna Sarkozy
  • Rosaline Quinlivan
  • John P. Bourke
  • Alessandra Ferlini
  • Inès Barthélémy
  • Linda H. Cripe
  • Emily Reuben
  • Teresinha Evangelista
  • Anca Florian
  • Josh Gribnau
  • Lidia Gonzalez-Quereda
  • Michela Guglieri
  • Erik Niks
  • Rahul Phadke
  • Luisa Politano
  • Ros Quinlivan
  • Vissing, John
  • Nicol Voermans
  • Elizabeth Vroom
  • Aleksandra Pietrusz
  • Fernanda Fortunato
  • Saskia Houwen
  • ENMC 263rd Workshop Study Group
OriginalsprogEngelsk
TidsskriftNeuromuscular Disorders
Vol/bind33
Udgave nummer3
Sider (fra-til)274-284
Antal sider11
ISSN0960-8966
DOI
StatusUdgivet - 2023
Begivenhed263rd ENMC International Workshop - Hoofddorp, Holland
Varighed: 13 maj 202215 maj 2022

Workshop

Workshop263rd ENMC International Workshop
LandHolland
ByHoofddorp
Periode13/05/202215/05/2022

Bibliografisk note

Funding Information:
The workshop was made possible thanks to the financial support of the European Neuromuscular Centre (ENMC) and ENMC main sponsors: Association Française contre les Myopathies (France) , Deutsche Gesellschaft für Muskelkranke (Germany) , Muscular Dystrophy Campaign (UK) , Muskelsvindfonden (Denmark) , Prinses Beatrix Fonds (The Netherlands) , Schweizerische Stiftung für die Erforschung der Muskelkrankheiten (Switzerland) , Telethon Foundation (Italy) , Spierziekten Nederland (The Netherlands) , and Associated members Partners: Finnish Neuromuscular Association (Finland) , Österreichische Muskelforschung (Austria) , SMA Europe and World Duchenne Organisation . In addition, we would like to thank the members of the ENMC Company Forum: Sanofi, Roche, Lupin Neuroscience, Amicus Therapeutics, Ionis Pharmaceuticals, Biogen, Novartis, PerkinElmer and Astellas.

ID: 367301955